These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37146728)

  • 21. Racial inequities in the quality of surgical care among Medicare beneficiaries with localized prostate cancer.
    Nyame YA; Holt SK; Etzioni RD; Gore JL
    Cancer; 2023 May; 129(9):1402-1410. PubMed ID: 36776124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of In-office Dispensing by Single-specialty Urology Practices on Management of Advanced Prostate Cancer.
    Lai LY; Kaufman SR; Oerline M; Caram MEV; Maganty A; Shahinian VB; Hollenbeck BK
    Urol Pract; 2023 May; 10(3):230-235. PubMed ID: 37103497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physician visits prior to treatment for clinically localized prostate cancer.
    Jang TL; Bekelman JE; Liu Y; Bach PB; Basch EM; Elkin EB; Zelefsky MJ; Scardino PT; Begg CB; Schrag D
    Arch Intern Med; 2010 Mar; 170(5):440-50. PubMed ID: 20212180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variation in use of active surveillance among men undergoing expectant treatment for early stage prostate cancer.
    Filson CP; Schroeck FR; Ye Z; Wei JT; Hollenbeck BK; Miller DC
    J Urol; 2014 Jul; 192(1):75-80. PubMed ID: 24518783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer.
    Fowler FJ; McNaughton Collins M; Albertsen PC; Zietman A; Elliott DB; Barry MJ
    JAMA; 2000 Jun; 283(24):3217-22. PubMed ID: 10866869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early effect of Medicare Shared Savings Program accountable care organization participation on prostate cancer care.
    Borza T; Kaufman SR; Yan P; Herrel LA; Luckenbaugh AN; Miller DC; Skolarus TA; Jacobs BL; Hollingsworth JM; Norton EC; Shahinian VB; Hollenbeck BK
    Cancer; 2018 Feb; 124(3):563-570. PubMed ID: 29053177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physician variation in management of low-risk prostate cancer: a population-based cohort study.
    Hoffman KE; Niu J; Shen Y; Jiang J; Davis JW; Kim J; Kuban DA; Perkins GH; Shah JB; Smith GL; Volk RJ; Buchholz TA; Giordano SH; Smith BD
    JAMA Intern Med; 2014 Sep; 174(9):1450-9. PubMed ID: 25023650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between hospital competition and quality of prostate cancer care.
    Jayadevappa R; Malkowicz SB; Vapiwala N; Guzzo TJ; Chhatre S
    BMC Health Serv Res; 2023 Aug; 23(1):828. PubMed ID: 37543580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contemporary Management of Incident Prostate Cancer in Large Community Urology Practices in the United States.
    Shelton JB; Buffington P; Augspurger R; Gaylis F; Cohen T; Mehlhaff B; Suh R; Bradford TJ; Kwan L; Koo AS; Shore N
    Urology; 2019 Jul; 129():79-86. PubMed ID: 30954610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of multispecialty care for low- and intermediate-risk prostate cancer in the use of active surveillance.
    Zambrano IA; Hwang S; Basak R; Spratte BN; Filson CP; Jacobs BL; Tan HJ
    Urol Oncol; 2023 Sep; 41(9):388.e1-388.e8. PubMed ID: 37286404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Competition in California's Medi-Cal Managed Care Market Assessed by Herfindahl-Hirschman Index.
    Tawil M; DiGiorgio AM
    Inquiry; 2022; 59():469580221127063. PubMed ID: 36168304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health Care Integration and Quality among Men with Prostate Cancer.
    Herrel LA; Kaufman SR; Yan P; Miller DC; Schroeck FR; Skolarus TA; Shahinian VB; Hollenbeck BK
    J Urol; 2017 Jan; 197(1):55-60. PubMed ID: 27423758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer.
    Tyson MD; Graves AJ; O'Neil B; Barocas DA; Chang SS; Penson DF; Resnick MJ
    JAMA Surg; 2017 Jan; 152(1):27-34. PubMed ID: 27653425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downstream tests, treatments, and annual direct payments in older men cared for by primary care providers with high or low prostate-specific antigen screening rates using 100 percent Texas U.S. Medicare public insurance claims data: a retrospective cohort study.
    Zanwar P; Lin YL; Kuo YF; Goodwin JS
    BMC Health Serv Res; 2016 Jan; 16():17. PubMed ID: 26772175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Provider Practice Competition and Adoption of Medicare's Oncology Care Model.
    Jalali A; Martin C; Nelson RE; Vanneman ME; Martin BI; Cooney KA; Waitzman NJ; O'Neil B
    Med Care; 2020 Feb; 58(2):154-160. PubMed ID: 31688568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
    Sadetsky N; Elkin EP; Latini DM; DuChane J; Carroll PR;
    Prostate Cancer Prostatic Dis; 2008; 11(3):280-7. PubMed ID: 17893700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perceptions of Prostate MRI and Fusion Biopsy of Radiation Oncologists and Urologists for Patients Diagnosed with Prostate Cancer: Results from a National Survey.
    Bukavina L; Tilburt JC; Konety B; Shah ND; Gross CP; Yu JB; Schumacher F; Kutikov A; Smaldone MC; Kim SP
    Eur Urol Focus; 2020 Mar; 6(2):273-279. PubMed ID: 30219709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of practice integration between urologists and radiation oncologists on prostate cancer treatment patterns.
    Bekelman JE; Suneja G; Guzzo T; Pollack CE; Armstrong K; Epstein AJ
    J Urol; 2013 Jul; 190(1):97-101. PubMed ID: 23399652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Change in Functional Status After Prostate Cancer Treatment Among Medicare Advantage Beneficiaries.
    Jacobs BL; Lopa SH; Yabes JG; Nelson JB; Barnato AE; Degenholtz HB
    Urology; 2019 Sep; 131():104-111. PubMed ID: 31181274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effects of Market Competition on Cardiologists' Adoption of Transcatheter Aortic Valve Replacement.
    Groeneveld PW; Yang L; Segal AG; Karaca-Mandic P; Kanter GP
    Med Care; 2020 Nov; 58(11):996-1003. PubMed ID: 32947511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.